Strategic Pharma Solutions merges MicroMass Communications

Strategic Pharma Solutions Inc, a portfolio company of Periscope Equity LLC, has merged with MicroMass Communications Inc. Financial terms weren’t announced. Cary, North Carolina-based MicroMass is MicroMass is a marketing agency that uses evidence-based behavior change strategies for patient health outcomes. OFS Capital Corp and Centerfield Capital Partners provided financing.


Strategic Pharma Solutions, Inc. (“SPS”), a portfolio company of Periscope Equity LLC (“Periscope”) and a leading medical communications and marketing services agency for the pharmaceutical, medical device, and biotechnology industries, is pleased to announce a strategic combination with MicroMass Communications, Inc. (“MicroMass”). Headquartered in Cary, North Carolina, MicroMass is a leading marketing agency focused on applying evidence-based behavior change strategies to create real-world solutions that optimize patient health outcomes.
The merger of SPS and MicroMass creates one of the largest independent, full-service, multi-channel healthcare marketing and medical communications agencies in the Southeast, with unique expertise in both human health behavior and healthcare professional advocacy.
With expertise in human health behavior, MicroMass builds fundamentally different marketing programs that help patients with chronic conditions, cancer, or rare diseases build the confidence and the skills they need to better engage in their care and help clients succeed in a value-based healthcare environment. MicroMass also delivers highly specialized services in key areas including patient engagement and support, relationship marketing, and pre-launch scientific communications.
By leveraging highly strategic and specialized patient and healthcare provider engagement capabilities, this new partnership provides clients with a differentiated range of competencies, inclusive of roles not generally garnered by a traditional agency. With more than twenty-five blue-chip pharmaceutical and medical devices clients, the merger best positions the combined organization to successfully address the ongoing changes in the healthcare marketplace.
OFS Capital Corporation and Centerfield Capital Partners provided financing to support the transaction.
For more information, visit MicroMass and SPS or see the press release.
About Periscope Equity LLC
Periscope is a Chicago-based, lower-middle market private equity firm focused exclusively on buyouts and significant minority investments in technology-enabled business services companies with $2 million to $5 million of EBITDA. Periscope targets companies with distinct paths of growth, differentiated service offerings, and strong cash flow generation. Providing financial capital, industry knowledge, and operational expertise, Periscope partners with proven management teams to grow businesses, both organically and through acquisitions